Voya Investment Management LLC Bridge Bio Pharma, Inc. Transaction History

Voya Investment Management LLC

$71.9 Billion
Q1 2025

A detailed history of Voya Investment Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 80,574 shares of BBIO stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,574

Previous 80,574 -0.0%

Holding current value

$3.69 Million

Previous $2.79 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$28.12 - $37.59 $254,795 - $340,602	9,061 Added 12.67%	80,574 $2.79 Million
Q4 2024 Feb 14, 2025	SELL	$22.35 - $29.5 $76,794 - $101,362	-3,436 Reduced 4.58%	71,513 $1.96 Million
Q3 2024 Feb 07, 2025	SELL	$23.91 - $31.3 $378,136 - $495,009	-15,815 Reduced 17.42%	74,949 $1.91 Million
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $378,136 - $495,009	-15,815 Reduced 17.42%	74,949 $1.91 Million
Q2 2024 Feb 07, 2025	SELL	$23.0 - $31.04 $1.78 Million - $2.4 Million	-77,212 Reduced 45.97%	90,764 $2.3 Million
Q2 2024 Dec 03, 2024	BUY	$23.0 - $31.04 $363,745 - $490,897	15,815 Added 21.1%	90,764 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $1.64 Million - $2.21 Million	-71,194 Reduced 43.96%	90,764 $2.3 Million
Q1 2024 Feb 07, 2025	BUY	$27.35 - $40.45 $2.54 Million - $3.76 Million	93,027 Added 124.12%	167,976 $5.19 Million
Q1 2024 Dec 06, 2024	BUY	$27.35 - $40.45 $2.38 Million - $3.52 Million	87,009 Added 116.09%	161,958 $5.01 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $685,473 - $1.01 Million	-25,063 Reduced 13.4%	161,958 $5.01 Million
Q4 2023 Feb 07, 2025	BUY	$24.02 - $43.89 $2.82 Million - $5.15 Million	117,398 Added 155.2%	193,039 $7.79 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $2.68 Million - $4.89 Million	111,380 Added 147.25%	187,021 $7.55 Million
Q3 2023 Feb 07, 2025	BUY	$16.89 - $35.01 $496,194 - $1.03 Million	29,378 Added 63.5%	75,641 $1.99 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $496,194 - $1.03 Million	29,378 Added 63.5%	75,641 $1.99 Million
Q2 2023 Feb 07, 2025	SELL	$13.29 - $18.01 $1.21 Million - $1.63 Million	-90,680 Reduced 66.22%	46,263 $795,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $1.21 Million - $1.63 Million	-90,680 Reduced 66.22%	46,263 $795,000
Q1 2023 Feb 07, 2025	BUY	$7.17 - $18.55 $444,496 - $1.15 Million	61,994 Added 82.71%	136,943 $2.27 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $683,767 - $1.77 Million	95,365 Added 229.36%	136,943 $2.27 Million
Q3 2022 Feb 07, 2025	SELL	$7.94 - $12.36 $264,965 - $412,465	-33,371 Reduced 44.52%	41,578 $413,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $5,485 - $25,743	-482 Reduced 1.15%	41,578 $694,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $14,951 - $20,492	-319 Reduced 0.75%	42,060 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $51,163 - $70,386	1,101 Added 2.67%	42,379 $2.58 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $531,957 - $693,836	9,590 Added 30.26%	41,278 $2.54 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $255,073 - $472,597	6,646 Added 26.54%	31,688 $2.25 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $18,360 - $28,478	-675 Reduced 2.62%	25,042 $940,000
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $251,552 - $404,046	-11,321 Reduced 30.57%	25,717 $839,000
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $422,065 - $949,189	26,199 Added 241.71%	37,038 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $194,668 - $505,422	10,839 New	10,839 $380,000

Others Institutions Holding BBIO

# of Institutions

370

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.79B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Bridge Bio Pharma, Inc. Transaction History